The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.

Kirsty Moore was diagnosed with a tumour in 2021, but despite four operations the mass has grown on her optic nerve - she has ...

A brave Scottish woman who was left with a bulging eye and a brain tumour after years of taking the contraceptive jab has ...

The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing time and ...

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the ...

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...

Pfizer’s Hympavzi receives European approval to treat adults and adolescents with haemophilia A or B with inhibitors: New York Thursday, May 14, 2026, 09:00 Hrs [IST] Pfizer Inc ...

Pfizer Inc. (NYSE: PFE)today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for ...

Five brave women have spoken to the Record and shared photographs of their serious health problems after years on the jab.

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...